Posts

Showing posts with the label Macular Degeneration

An Overview on High Blood Pressure and Eye Diseases

Image
Did you know that your vision connected to other aspects of well-being in a manner way that you don’t always expect? For example, hypertension and circulatory problems may increase your risk of various retinal disorders and illnesses.  Thankfully, Windy city retina in Plainfield, Illinois, where Dr. Ankit Desai is a retina specialist dedicated to offering advanced retina care and focus on prevention and long-term wellness. Consider the dangers of high blood pressure and look at a few retinal conditions that this can cause.  Understand the Danger of Hypertension If you suffer from hypertension, you are at increased risk for several health problems and conditions. This is to be expected when your circulation is impaired. This includes heart attack, stroke, aneurysms, and cognitive issues. In addition to affecting your general wellbeing significantly, high blood pressure can also lead to many vision problems. Let us take a view on retinal problems most commonly associated with hi...

New Therapeutic Approach for Treatment of Age-Related Macular Degeneration

Image
The scientists discovered that the inhibition of Runt-bound transcription factor 1 (RUNX1), which has been linked to retinal neovascularization and the development of abnormal blood vessels leading to vision loss, presents a new therapy approach to treat age-related macular degeneration (AMD). Their results are published in the American Journal of Pathology . Abnormal growth of blood vessels, or aberrant angiogenesis, originates from the choroid, a portion of the eye behind the retina. This condition, known as choroidal neovascularization (CNV), is present in many eye diseases that lead to blindness like AMD. This study is the first to include RUNX1 in CNV and to test RUNX1 inhibition therapy for the treatment of CNV. The researchers found that the application of a RUNX1 inhibitor alone or in combination with standard therapy for AMD may represent a significant therapeutic advance. The incomplete response to anti-vascular drugs with endothelial growth factor (VEGF) is a critical probl...